Related Experiment Video
Updated: Apr 27, 2026

Immunopeptidomics: Isolation of Mouse and Human MHC Class I- and II-Associated Peptides for Mass Spectrometry Analysis
Published on: October 15, 2021
Susceptibility to HLA-DM protein is determined by a dynamic conformation of major histocompatibility complex class II
Liusong Yin1, Peter Trenh1, Abigail Guce2
1From the Program in Immunology and Microbiology and.
Abstract:
HLA-DM mediates the exchange of peptides loaded onto MHCII molecules during antigen presentation by a mechanism that remains unclear and controversial. Here, we investigated the sequence and structural determinants of HLA-DM interaction. Peptides interacting nonoptimally in the P1 pocket exhibited low MHCII binding affinity and kinetic instability and were highly susceptible to HLA-DM-mediated peptide exchange. These changes were accompanied by conformational alterations detected by surface plasmon resonance, SDS resistance assay, antibody binding assay, gel filtration, dynamic light scattering, small angle x-ray scattering, and NMR spectroscopy. Surprisingly, all of those changes could be reversed by substitution of the P9 pocket anchor residue. Moreover, MHCII mutations outside the P1 pocket and the HLA-DM interaction site increased HLA-DM susceptibility. These results indicate that a dynamic MHCII conformational determinant rather than P1 pocket occupancy is the key factor determining susceptibility to HLA-DM-mediated peptide exchange and provide a molecular mechanism for HLA-DM to efficiently target unstable MHCII-peptide complexes for editing and exchange those for more stable ones.
Insights
Human Leukocyte Antigen - Antigen Presentation System (HLA-DM) facilitates peptide exchange on MHCII molecules. Unstable MHCII-peptide complexes, not just P1 pocket occupancy, drive this exchange, revealing a dynamic conformational mechanism.
Area of Science:
- Immunology
- Molecular Biology
- Structural Biology
Background:
- Human Leukocyte Antigen - Antigen Presentation System (HLA-DM) plays a critical role in adaptive immunity by mediating peptide exchange on Major Histocompatibility Complex class II (MHCII) molecules.
- The precise mechanism by which HLA-DM identifies and facilitates the exchange of peptides loaded onto MHCII remains incompletely understood and debated.
- Non-optimal peptide binding to MHCII can lead to unstable complexes, impacting antigen presentation efficiency.
Purpose of the Study:
- To elucidate the sequence and structural determinants governing the interaction between HLA-DM and MHCII-peptide complexes.
- To investigate the role of peptide binding pockets, particularly P1 and P9, in MHCII susceptibility to HLA-DM-mediated peptide exchange.
- To understand the conformational dynamics of MHCII molecules that influence their interaction with HLA-DM.
Main Methods:
- Investigated the impact of non-optimal peptide binding on MHCII affinity and stability.
- Utilized a suite of biophysical techniques including surface plasmon resonance (SPR), SDS resistance assays, antibody binding assays, gel filtration, dynamic light scattering (DLS), small-angle X-ray scattering (SAXS), and Nuclear Magnetic Resonance (NMR) spectroscopy.
- Examined the effects of specific MHCII mutations, including those in the P1 and P9 pockets and outside the HLA-DM interaction site, on HLA-DM susceptibility.
Main Results:
- Non-optimally bound peptides in the P1 pocket resulted in low MHCII binding affinity, kinetic instability, and increased susceptibility to HLA-DM-mediated exchange.
- These changes were associated with detectable conformational alterations in MHCII molecules.
- Crucially, these conformational changes and susceptibility to exchange were reversible by altering the P9 pocket anchor residue, and mutations outside the P1 pocket also increased susceptibility, highlighting a dynamic conformational determinant.
Conclusions:
- Susceptibility to HLA-DM-mediated peptide exchange is primarily determined by dynamic MHCII conformational states rather than solely by P1 pocket occupancy.
- HLA-DM efficiently targets and edits unstable MHCII-peptide complexes, replacing them with more stable peptide ligands.
- This study provides a molecular mechanism for HLA-DM's function in optimizing antigen presentation through conformational surveillance of MHCII molecules.
Related Concept Videos
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and...
Antigen Processing Pathways
MHC Class I: Presenting Endogenous...
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Diversity of Antigen Receptors
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...

